Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
pantoprazole sodium sesquihydrate, Quantity: 22.6 mg (Equivalent: pantoprazole sodium sesquihydrate, Qty 20 mg; Equivalent: pantoprazole, Qty 20 mg)
Arrotex Pharmaceuticals Pty Ltd
Pantoprazole sodium sesquihydrate
Tablet, enteric coated
Excipient Ingredients: microcrystalline cellulose; methacrylic acid copolymer; magnesium stearate; crospovidone; triethyl citrate; iron oxide yellow; sodium carbonate; titanium dioxide; macrogol 8000; lactose; purified talc; hypromellose
Oral
7, 14
Medicine Registered
(S2) Pharmacy Medicine, (S3) Pharmacist Only Medicine
Gastroesophageal reflux disease (GORD). Symptomatic GORD: the treatment of heartburn and other symptoms associated with GORD.
Visual Identification: Yellow, oval, biconvex, enteric-coated tablet. Engrave "APO" on one side, "20" on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius
Licence status A
2009-12-09